Literature Search

Geyer(Felipe C),Berman(Samuel H),Marchiò(Cat… Mod Pathol 0000-00-00

...PIK3CA, and INPP4B. Recurrent (n=2) somatic mutations restricted to microglandular adenosis or acinic cell carcinomas in...

Pai(Reetesh K),Chen(Yuwei),Jakubowski(Mauree… Mod Pathol 0000-00-00

...PIK3CA and AKT, P=0.02). In conclusion, this study demonstrates the importance of identifying high tumor budding in pT1 ...

Han(Na),Cheng(Qiao-Yuan),Chen(Bo),Cai(Ju-Fen… Adv Clin Exp Med 0000-00-00

...PIK3CA) gene, which encodes the p110α catalytic subunit, plays a key role in the activation of AKT downstream signaling ...

Gorges(Tobias M),Kuske(Andra),Röck(Katharina… Clin Chem 0000-00-00

...PIK3CA and MTOR) or cross talks between tumors and immune cells (e.g., CCL4, CXCL2, CXCL9, IL15, IL1B, or IL8).,Multimar...

Sayagués(José María),Corchete(Luís Antonio),… Oncotarget 0000-00-00

...PIK3CA, PTEN and EGFR), endocytosis (e.g., the PDGFRA, SMAD2, ERBB3, PML and FGFR2), and the cell cycle (e.g., SMAD2, CC...

Smid(Marcel),Rodríguez-González(F Germán),Si… Nat Commun 0000-00-00

...PIK3CA, PTEN, CCND1 and CDH1. We find that CCND3 expression levels do not correlate with amplification, while increased ...

Kim(Minchul),Lu(Falong),Zhang(Yi) Cell Rep 0000-00-00

ARID1A is frequently mutated in ovarian clear cell carcinoma (OCCC) and often co-exists with activating mutations of PIK...

Yoh(Kathryn E),Regunath(Kausik),Guzman(Asja)… Proc Natl Acad Sci U S A 0000-00-00

...PIK3CA) oncogenes strongly repress expression of ∆Np63α, the predominant p63 isoform in basal mammary epithelial cells. ...

Fumagalli(D),Wilson(T R),Salgado(R),Lu(X),Yu… Ann Oncol 0000-00-00

...PIK3CA, KRAS, AKT1, FGFR3, HRAS and BRAF at frequencies of 41%, 6%, 5%, 2%, 1% and 2%, respectively, and CN amplificatio...

Patnaik(A),Appleman(L J),Tolcher(A W),Papado… Ann Oncol 0000-00-00

...PIK3CA, KRAS, BRAF, and PTEN mutational status and PTEN immunohistochemistry. Whole-body [(18)F]-fluorodeoxyglucose posi...